Invenomic Capital Management’s Clarivate CLVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$33.7M Buy
13,310,234
+4,280,820
+47% +$11M 1.55% 17
2025
Q4
$30.2M Buy
9,029,414
+326,369
+4% +$1.16M 1.4% 19
2025
Q3
$33.3M Sell
8,703,045
-682,042
-7% -$2.86M 1.61% 17
2025
Q2
$40.4M Buy
9,385,087
+904,791
+11% +$3.64M 2.29% 6
2025
Q1
$33.3M Buy
8,480,296
+1,894,589
+29% +$8.97M 1.68% 14
2024
Q4
$33.5M Buy
6,585,707
+667,146
+11% +$3.84M 1.59% 10
2024
Q3
$42M Sell
5,918,561
-835,912
-12% -$5.33M 2.31% 7
2024
Q2
$38.4M Buy
6,754,473
+342,557
+5% +$2.18M 1.87% 10
2024
Q1
$47.6M Buy
6,411,916
+1,453,428
+29% +$12.1M 2.53% 2
2023
Q4
$45.9M Sell
4,958,488
-2,527,756
-34% -$18.7M 2.09% 7
2023
Q3
$50.2M Buy
7,486,244
+763,368
+11% +$6.09M 2.11% 9
2023
Q2
$64.1M Buy
6,722,876
+1,253,238
+23% +$10.6M 3.25% 2
2023
Q1
$51.4M Buy
5,469,638
+2,664,472
+95% +$27.5M 2.9% 2
2022
Q4
$23.4M Buy
+2,805,166
New +$26.3M 1.59% 18

Other funds holding CLVT